Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma

Autores
Croci, D.O.; Salatino, M.; Rubinstein, N.; Cerliani, J.P.; Cavallin, L.E.; Leung, H.J.; Ouyang, J.; Ilarregui, J.M.; Toscano, M.A.; Domaica, C.I.; Croci, M.C.; Shipp, M.A.; Mesri, E.A.; Albini, A.; Rabinovich, G.A.
Año de publicación
2012
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Kaposi's sarcoma (KS), a multifocal vascular neoplasm linked to human herpesvirus-8 (HHV-8/KS-associated herpesvirus [KSHV]) infection, is the most common AIDS-associated malignancy. Clinical management of KS has proven to be challenging because of its prevalence in immunosuppressed patients and its unique vascular and inflammatory nature that is sustained by viral and host-derived paracrine-acting factors primarily released under hypoxic conditions. We show that interactions between the regulatory lectin galectin-1 (Gal-1) and specific target N-glycans link tumor hypoxia to neovascularization as part of the pathogenesis of KS. Expression of Gal-1 is found to be a hallmark of human KS but not other vascular pathologies and is directly induced by both KSHV and hypoxia. Interestingly, hypoxia induced Gal-1 through mechanisms that are independent of hypoxia-inducible factor (HIF) 1α and HIF-2α but involved reactive oxygen species-dependent activation of the transcription factor nuclear factor κB. Targeted disruption of Gal-1-N-glycan interactions eliminated hypoxia-driven angiogenesis and suppressed tumorigenesis in vivo. Therapeutic administration of a Gal-1-specific neutralizing mAb attenuated abnormal angiogenesis and promoted tumor regression in mice bearing established KS tumors. Given the active search for HIF-independent mechanisms that serve to couple tumor hypoxia to pathological angiogenesis, our findings provide novel opportunities not only for treating KS patients but also for understanding and managing a variety of solid tumors. © 2012 Croci et al.
Fil:Croci, D.O. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.
Fil:Salatino, M. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.
Fil:Rubinstein, N. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.
Fil:Ilarregui, J.M. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.
Fil:Toscano, M.A. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.
Fil:Domaica, C.I. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.
Fil:Mesri, E.A. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.
Fuente
J. Exp. Med. 2012;209(11):1985-2000
Materia
galectin 1
glycan
hypoxia inducible factor 1alpha
hypoxia inducible factor 2alpha
immunoglobulin enhancer binding protein
messenger RNA
monoclonal antibody
reactive oxygen metabolite
angiogenesis
animal cell
animal experiment
animal model
animal tissue
apoptosis
article
carcinogenesis
cell growth
cell invasion
cell migration
cell proliferation
controlled study
human
human cell
human tissue
hypoxia
in vivo study
Kaposi sarcoma
male
mouse
nonhuman
priority journal
protein expression
protein function
protein protein interaction
protein targeting
spindle cell
tumor regression
Animals
Anoxia
Antibodies, Monoclonal
Antibodies, Neutralizing
Cell Hypoxia
Cell Line, Tumor
Cells, Cultured
Galectin 1
Gene Expression Regulation, Neoplastic
HEK293 Cells
Herpesvirus 8, Human
Host-Pathogen Interactions
Humans
Immunoblotting
Mice
Mice, Inbred C57BL
Mice, Knockout
Mice, Nude
Neovascularization, Pathologic
Polysaccharides
Protein Binding
Reverse Transcriptase Polymerase Chain Reaction
RNA Interference
Sarcoma, Kaposi
Xenograft Model Antitumor Assays
Nivel de accesibilidad
acceso abierto
Condiciones de uso
http://creativecommons.org/licenses/by/2.5/ar
Repositorio
Biblioteca Digital (UBA-FCEN)
Institución
Universidad Nacional de Buenos Aires. Facultad de Ciencias Exactas y Naturales
OAI Identificador
paperaa:paper_00221007_v209_n11_p1985_Croci

id BDUBAFCEN_01f9c459cd456ae07cecee5d85240ce5
oai_identifier_str paperaa:paper_00221007_v209_n11_p1985_Croci
network_acronym_str BDUBAFCEN
repository_id_str 1896
network_name_str Biblioteca Digital (UBA-FCEN)
spelling Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcomaCroci, D.O.Salatino, M.Rubinstein, N.Cerliani, J.P.Cavallin, L.E.Leung, H.J.Ouyang, J.Ilarregui, J.M.Toscano, M.A.Domaica, C.I.Croci, M.C.Shipp, M.A.Mesri, E.A.Albini, A.Rabinovich, G.A.galectin 1glycanhypoxia inducible factor 1alphahypoxia inducible factor 2alphaimmunoglobulin enhancer binding proteinmessenger RNAmonoclonal antibodyreactive oxygen metaboliteangiogenesisanimal cellanimal experimentanimal modelanimal tissueapoptosisarticlecarcinogenesiscell growthcell invasioncell migrationcell proliferationcontrolled studyhumanhuman cellhuman tissuehypoxiain vivo studyKaposi sarcomamalemousenonhumanpriority journalprotein expressionprotein functionprotein protein interactionprotein targetingspindle celltumor regressionAnimalsAnoxiaAntibodies, MonoclonalAntibodies, NeutralizingCell HypoxiaCell Line, TumorCells, CulturedGalectin 1Gene Expression Regulation, NeoplasticHEK293 CellsHerpesvirus 8, HumanHost-Pathogen InteractionsHumansImmunoblottingMiceMice, Inbred C57BLMice, KnockoutMice, NudeNeovascularization, PathologicPolysaccharidesProtein BindingReverse Transcriptase Polymerase Chain ReactionRNA InterferenceSarcoma, KaposiXenograft Model Antitumor AssaysKaposi's sarcoma (KS), a multifocal vascular neoplasm linked to human herpesvirus-8 (HHV-8/KS-associated herpesvirus [KSHV]) infection, is the most common AIDS-associated malignancy. Clinical management of KS has proven to be challenging because of its prevalence in immunosuppressed patients and its unique vascular and inflammatory nature that is sustained by viral and host-derived paracrine-acting factors primarily released under hypoxic conditions. We show that interactions between the regulatory lectin galectin-1 (Gal-1) and specific target N-glycans link tumor hypoxia to neovascularization as part of the pathogenesis of KS. Expression of Gal-1 is found to be a hallmark of human KS but not other vascular pathologies and is directly induced by both KSHV and hypoxia. Interestingly, hypoxia induced Gal-1 through mechanisms that are independent of hypoxia-inducible factor (HIF) 1α and HIF-2α but involved reactive oxygen species-dependent activation of the transcription factor nuclear factor κB. Targeted disruption of Gal-1-N-glycan interactions eliminated hypoxia-driven angiogenesis and suppressed tumorigenesis in vivo. Therapeutic administration of a Gal-1-specific neutralizing mAb attenuated abnormal angiogenesis and promoted tumor regression in mice bearing established KS tumors. Given the active search for HIF-independent mechanisms that serve to couple tumor hypoxia to pathological angiogenesis, our findings provide novel opportunities not only for treating KS patients but also for understanding and managing a variety of solid tumors. © 2012 Croci et al.Fil:Croci, D.O. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.Fil:Salatino, M. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.Fil:Rubinstein, N. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.Fil:Ilarregui, J.M. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.Fil:Toscano, M.A. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.Fil:Domaica, C.I. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.Fil:Mesri, E.A. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.2012info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfhttp://hdl.handle.net/20.500.12110/paper_00221007_v209_n11_p1985_CrociJ. Exp. Med. 2012;209(11):1985-2000reponame:Biblioteca Digital (UBA-FCEN)instname:Universidad Nacional de Buenos Aires. Facultad de Ciencias Exactas y Naturalesinstacron:UBA-FCENenginfo:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by/2.5/ar2025-09-04T09:48:47Zpaperaa:paper_00221007_v209_n11_p1985_CrociInstitucionalhttps://digital.bl.fcen.uba.ar/Universidad públicaNo correspondehttps://digital.bl.fcen.uba.ar/cgi-bin/oaiserver.cgiana@bl.fcen.uba.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:18962025-09-04 09:48:49.372Biblioteca Digital (UBA-FCEN) - Universidad Nacional de Buenos Aires. Facultad de Ciencias Exactas y Naturalesfalse
dc.title.none.fl_str_mv Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma
title Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma
spellingShingle Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma
Croci, D.O.
galectin 1
glycan
hypoxia inducible factor 1alpha
hypoxia inducible factor 2alpha
immunoglobulin enhancer binding protein
messenger RNA
monoclonal antibody
reactive oxygen metabolite
angiogenesis
animal cell
animal experiment
animal model
animal tissue
apoptosis
article
carcinogenesis
cell growth
cell invasion
cell migration
cell proliferation
controlled study
human
human cell
human tissue
hypoxia
in vivo study
Kaposi sarcoma
male
mouse
nonhuman
priority journal
protein expression
protein function
protein protein interaction
protein targeting
spindle cell
tumor regression
Animals
Anoxia
Antibodies, Monoclonal
Antibodies, Neutralizing
Cell Hypoxia
Cell Line, Tumor
Cells, Cultured
Galectin 1
Gene Expression Regulation, Neoplastic
HEK293 Cells
Herpesvirus 8, Human
Host-Pathogen Interactions
Humans
Immunoblotting
Mice
Mice, Inbred C57BL
Mice, Knockout
Mice, Nude
Neovascularization, Pathologic
Polysaccharides
Protein Binding
Reverse Transcriptase Polymerase Chain Reaction
RNA Interference
Sarcoma, Kaposi
Xenograft Model Antitumor Assays
title_short Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma
title_full Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma
title_fullStr Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma
title_full_unstemmed Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma
title_sort Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma
dc.creator.none.fl_str_mv Croci, D.O.
Salatino, M.
Rubinstein, N.
Cerliani, J.P.
Cavallin, L.E.
Leung, H.J.
Ouyang, J.
Ilarregui, J.M.
Toscano, M.A.
Domaica, C.I.
Croci, M.C.
Shipp, M.A.
Mesri, E.A.
Albini, A.
Rabinovich, G.A.
author Croci, D.O.
author_facet Croci, D.O.
Salatino, M.
Rubinstein, N.
Cerliani, J.P.
Cavallin, L.E.
Leung, H.J.
Ouyang, J.
Ilarregui, J.M.
Toscano, M.A.
Domaica, C.I.
Croci, M.C.
Shipp, M.A.
Mesri, E.A.
Albini, A.
Rabinovich, G.A.
author_role author
author2 Salatino, M.
Rubinstein, N.
Cerliani, J.P.
Cavallin, L.E.
Leung, H.J.
Ouyang, J.
Ilarregui, J.M.
Toscano, M.A.
Domaica, C.I.
Croci, M.C.
Shipp, M.A.
Mesri, E.A.
Albini, A.
Rabinovich, G.A.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv galectin 1
glycan
hypoxia inducible factor 1alpha
hypoxia inducible factor 2alpha
immunoglobulin enhancer binding protein
messenger RNA
monoclonal antibody
reactive oxygen metabolite
angiogenesis
animal cell
animal experiment
animal model
animal tissue
apoptosis
article
carcinogenesis
cell growth
cell invasion
cell migration
cell proliferation
controlled study
human
human cell
human tissue
hypoxia
in vivo study
Kaposi sarcoma
male
mouse
nonhuman
priority journal
protein expression
protein function
protein protein interaction
protein targeting
spindle cell
tumor regression
Animals
Anoxia
Antibodies, Monoclonal
Antibodies, Neutralizing
Cell Hypoxia
Cell Line, Tumor
Cells, Cultured
Galectin 1
Gene Expression Regulation, Neoplastic
HEK293 Cells
Herpesvirus 8, Human
Host-Pathogen Interactions
Humans
Immunoblotting
Mice
Mice, Inbred C57BL
Mice, Knockout
Mice, Nude
Neovascularization, Pathologic
Polysaccharides
Protein Binding
Reverse Transcriptase Polymerase Chain Reaction
RNA Interference
Sarcoma, Kaposi
Xenograft Model Antitumor Assays
topic galectin 1
glycan
hypoxia inducible factor 1alpha
hypoxia inducible factor 2alpha
immunoglobulin enhancer binding protein
messenger RNA
monoclonal antibody
reactive oxygen metabolite
angiogenesis
animal cell
animal experiment
animal model
animal tissue
apoptosis
article
carcinogenesis
cell growth
cell invasion
cell migration
cell proliferation
controlled study
human
human cell
human tissue
hypoxia
in vivo study
Kaposi sarcoma
male
mouse
nonhuman
priority journal
protein expression
protein function
protein protein interaction
protein targeting
spindle cell
tumor regression
Animals
Anoxia
Antibodies, Monoclonal
Antibodies, Neutralizing
Cell Hypoxia
Cell Line, Tumor
Cells, Cultured
Galectin 1
Gene Expression Regulation, Neoplastic
HEK293 Cells
Herpesvirus 8, Human
Host-Pathogen Interactions
Humans
Immunoblotting
Mice
Mice, Inbred C57BL
Mice, Knockout
Mice, Nude
Neovascularization, Pathologic
Polysaccharides
Protein Binding
Reverse Transcriptase Polymerase Chain Reaction
RNA Interference
Sarcoma, Kaposi
Xenograft Model Antitumor Assays
dc.description.none.fl_txt_mv Kaposi's sarcoma (KS), a multifocal vascular neoplasm linked to human herpesvirus-8 (HHV-8/KS-associated herpesvirus [KSHV]) infection, is the most common AIDS-associated malignancy. Clinical management of KS has proven to be challenging because of its prevalence in immunosuppressed patients and its unique vascular and inflammatory nature that is sustained by viral and host-derived paracrine-acting factors primarily released under hypoxic conditions. We show that interactions between the regulatory lectin galectin-1 (Gal-1) and specific target N-glycans link tumor hypoxia to neovascularization as part of the pathogenesis of KS. Expression of Gal-1 is found to be a hallmark of human KS but not other vascular pathologies and is directly induced by both KSHV and hypoxia. Interestingly, hypoxia induced Gal-1 through mechanisms that are independent of hypoxia-inducible factor (HIF) 1α and HIF-2α but involved reactive oxygen species-dependent activation of the transcription factor nuclear factor κB. Targeted disruption of Gal-1-N-glycan interactions eliminated hypoxia-driven angiogenesis and suppressed tumorigenesis in vivo. Therapeutic administration of a Gal-1-specific neutralizing mAb attenuated abnormal angiogenesis and promoted tumor regression in mice bearing established KS tumors. Given the active search for HIF-independent mechanisms that serve to couple tumor hypoxia to pathological angiogenesis, our findings provide novel opportunities not only for treating KS patients but also for understanding and managing a variety of solid tumors. © 2012 Croci et al.
Fil:Croci, D.O. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.
Fil:Salatino, M. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.
Fil:Rubinstein, N. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.
Fil:Ilarregui, J.M. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.
Fil:Toscano, M.A. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.
Fil:Domaica, C.I. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.
Fil:Mesri, E.A. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.
description Kaposi's sarcoma (KS), a multifocal vascular neoplasm linked to human herpesvirus-8 (HHV-8/KS-associated herpesvirus [KSHV]) infection, is the most common AIDS-associated malignancy. Clinical management of KS has proven to be challenging because of its prevalence in immunosuppressed patients and its unique vascular and inflammatory nature that is sustained by viral and host-derived paracrine-acting factors primarily released under hypoxic conditions. We show that interactions between the regulatory lectin galectin-1 (Gal-1) and specific target N-glycans link tumor hypoxia to neovascularization as part of the pathogenesis of KS. Expression of Gal-1 is found to be a hallmark of human KS but not other vascular pathologies and is directly induced by both KSHV and hypoxia. Interestingly, hypoxia induced Gal-1 through mechanisms that are independent of hypoxia-inducible factor (HIF) 1α and HIF-2α but involved reactive oxygen species-dependent activation of the transcription factor nuclear factor κB. Targeted disruption of Gal-1-N-glycan interactions eliminated hypoxia-driven angiogenesis and suppressed tumorigenesis in vivo. Therapeutic administration of a Gal-1-specific neutralizing mAb attenuated abnormal angiogenesis and promoted tumor regression in mice bearing established KS tumors. Given the active search for HIF-independent mechanisms that serve to couple tumor hypoxia to pathological angiogenesis, our findings provide novel opportunities not only for treating KS patients but also for understanding and managing a variety of solid tumors. © 2012 Croci et al.
publishDate 2012
dc.date.none.fl_str_mv 2012
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/20.500.12110/paper_00221007_v209_n11_p1985_Croci
url http://hdl.handle.net/20.500.12110/paper_00221007_v209_n11_p1985_Croci
dc.language.none.fl_str_mv eng
language eng
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
http://creativecommons.org/licenses/by/2.5/ar
eu_rights_str_mv openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by/2.5/ar
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv J. Exp. Med. 2012;209(11):1985-2000
reponame:Biblioteca Digital (UBA-FCEN)
instname:Universidad Nacional de Buenos Aires. Facultad de Ciencias Exactas y Naturales
instacron:UBA-FCEN
reponame_str Biblioteca Digital (UBA-FCEN)
collection Biblioteca Digital (UBA-FCEN)
instname_str Universidad Nacional de Buenos Aires. Facultad de Ciencias Exactas y Naturales
instacron_str UBA-FCEN
institution UBA-FCEN
repository.name.fl_str_mv Biblioteca Digital (UBA-FCEN) - Universidad Nacional de Buenos Aires. Facultad de Ciencias Exactas y Naturales
repository.mail.fl_str_mv ana@bl.fcen.uba.ar
_version_ 1842340708234559488
score 12.623145